NFE2L2 and lung carcinoma: This study confirmed that metformin could induce ferroptosis in lung cancer cells by increasing oxidative stress and inhibiting the Nrf2/HO-1 signaling pathway, expanding the potential clinical application range of the cheap drug metformin, providing potential therapeutic agents for lung cancer patients.